Tag: Pharma
MaaT Pharma presents its objectives and the next stages of development for the year 2022 – 01/17/2022 at 18:10
• Important clinical milestones are expected for 2022 for the Company’s hemato-oncology and immuno-oncology programs. • MaaT013, MaaT Pharma’s most advanced Microbiome Ecosystem Therapy, is ready to enter a Phase…
MEDESIS PHARMA CONFIRMS ITS ELIGIBILITY FOR PEA-PME – 2022-01-14 at 18:00
Montpellier, January 14, 2022 – 6:00 p.m. – Medesis Pharma, a pharmaceutical biotechnology company developing drug candidates based on its proprietary technology for the administration of active ingredients in nano…
Biotech companies are increasingly moving back into the focus of Big Pharma
The twenty largest drug manufacturers alone could spend an estimated $ 1,700 billion on acquisitions. So far, in addition to the pandemic, the high ratings of biotech companies have been…
Pherecydes Pharma: the PhagECOLI project receives a grant of 2 ME from Bpifrance
Through Alexandra Saintpierre Posted on 01/03/2022 at 7:54 p.m. Photo credit © Reuters (Boursier.com) – The biotechnology company Pherecydes Pharma and the CEA announce the selection of the PhagECOLI project…
Abionyx Pharma receives an AAC by the ANSM for CER-001 in COVID-19
Through Alexandra Saintpierre Posted on 01/03/2022 at 8:21 p.m. Photo credit © Reuters (Boursier.com) – The National Medicines Safety Agency (ANSM) has granted a Compassionate Access Authorization (AAC) for bio-HDL…
Innate Pharma: investor meeting
JN.L. Posted on 01/04/2022 8:05 AM Photo credit © Reuters (Boursier.com) – Innate Pharma will participate in several virtual investor conferences in the coming days, namely the ODDO BHF Digital…
Innate Pharma: obtaining two PGEs
(CercleFinance.com) – Innate Pharma announces that it has obtained non-dilutive financing of 28.7 million euros in the form of two State Guaranteed Loans (PGE) from Société Générale and BNP Paribas,…
Innate Pharma: two EMPs for 28.7 million euros
Innate Pharma has obtained non-dilutive financing of 28.7 million euros in the form of two State Guaranteed Loans (PGE) from Socit Gnrale and BNP Paribas. These two loans have an…
Pherecydes Pharma receives enough to finance half of its PhagECOLI project
Subscribe for 1 € Unlimited access to all advice Over 800 securities listed in Paris and abroad scrutinized. To buy ? To sell ? What course objective? Our experts get…
Abionyx Pharma doped on the stock market by an authorization from the ANSM
Biotech has been granted a Compassionate Access Authorization (AAC) for its bio-HDL (CER-001) in Covid-19. Abionyx Pharma doped on the stock market by an authorization from the ANSM | Photo…
MaaT Pharma announces its participation in the HC Wainwright BioConnect 2022 virtual conference – 03/01/2022 at 19:02
Lyon, France, January 3, 2022 – 7:00 p.m. CET – MaaT Pharma (EURONEXT: “MAAT”), a French biotechnology company in advanced clinical stages, pioneer in the development of drugs in the…
Noxxon Pharma: extension of a financing agreement – 12/30/2021 at 11:42 am
(CercleFinance.com) – Noxxon Pharma announces the extension of its agreement with Atlas Special Opportunities (ASO), allowing a capital increase which further strengthens the financial visibility of the biotech company until…